Site-specific genomic integration produces therapeutic Factor IX levels in mice

EC Olivares, RP Hollis, TW Chalberg, L Meuse… - nature …, 2002 - nature.com
EC Olivares, RP Hollis, TW Chalberg, L Meuse, MA Kay, MP Calos
nature biotechnology, 2002nature.com
We used the integrase from phage φC31 to integrate the human Factor IX (hFIX) gene
permanently into specific sites in the mouse genome. A plasmid containing attB and an
expression cassette for hFIX was delivered to the livers of mice by using high-pressure tail
vein injection. When an integrase expression plasmid was co-injected, hFIX serum levels
increased more than tenfold to∼ 4 μg/ml, similar to normal FIX levels, and remained stable
throughout the more than eight months of the experiment. hFIX levels persisted after partial …
Abstract
We used the integrase from phage φC31 to integrate the human Factor IX (hFIX) gene permanently into specific sites in the mouse genome. A plasmid containing attB and an expression cassette for hFIX was delivered to the livers of mice by using high-pressure tail vein injection. When an integrase expression plasmid was co-injected, hFIX serum levels increased more than tenfold to ∼4 μg/ml, similar to normal FIX levels, and remained stable throughout the more than eight months of the experiment. hFIX levels persisted after partial hepatectomy, suggesting genomic integration of the vector. Site-specific integration was proven by characterizing and quantifying genomic integration in the liver at the DNA level. Integration was documented at two pseudo-attP sites, native sequences with partial identity to attP, with one site highly predominant. This study demonstrates in vivo gene transfer in an animal by site-specific genomic integration.
nature.com